Funding for this research was provided by:
Ministerio de economia y competitividad (PGC2018-094025-B-I00)
Ministerio de EconomÃa y Competitividad (PID2019-107160RB-I00)
Article History
Accepted: 25 May 2021
First Online: 12 July 2021
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
: Not applicable.
: Not applicable.
: LB declares to have acted as SAB member of Sanofi, Bayer, AstraZeneca, and the International Aspirin Foundation; has a research grant from AstraZeneca, speaker fees from Lilly, MSD-Boerhinger, and AstraZeneca; and to have founded the Spin-offs Glycardial Diagnostics SL. and IVESTATIN Therapeutics SL. (all outside of the area of the present work). GV has a research grant from AstraZeneca and is founder of the Spin-offs Glycardial Diagnostics SL. and IVESTATIN Therapeutics SL. (all outside of the area of the present work).